IL36G and Other metabolic disease: To further determine what impact, if any, increased IL-36γ might play in the pathogenesis of obesity and metabolic disease, we examined whether elevated expression levels were correlated with established clinical and biochemical parameters of disease recorded for each patient subgroup.